Development and optimization of proniosomal gel containing etodolac: in-vitro, ex-vivo and in-vivo evaluation
Abstract Introduction: Etodolac is used in the treatment of acute pain and inflammation. It has low solubility because of high hydrophobicity and it is reported that upon oral administration shows gastric disturbances. This encourages the development of topical vesicular formulation. Method: In...
Main Authors: | Moreshwar Patil, Prashant Pandit, Pavan Udavant, Sandeep Sonawane, Deepak Bhambere |
---|---|
Format: | Article |
Language: | English |
Published: |
Facultad de Farmacia, Universidad de Granada
2021-09-01
|
Series: | Ars Pharmaceutica |
Subjects: | |
Online Access: | http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2340-98942021000300290&tlng=en |
Similar Items
-
Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies
by: Ghada A. Abdelbary, et al.
Published: (2017-01-01) -
Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies
by: Salwa Salah, et al.
Published: (2017-01-01) -
Curcumin Niosomes Prepared from Proniosomal Gels: In Vitro Skin Permeability, Kinetic and In Vivo Studies
by: Tamer M. Shehata, et al.
Published: (2021-03-01) -
Formulation and Characterization of Proniosomal Gels loaded with Levofloxacin for dermal drug Delivery.
by: Lina K. Abdel Salam, et al.
Published: (2022-03-01) -
R-etodolac is a more potent Wnt signaling inhibitor than enantiomer, S-etodolac
by: JoAnn S. Roberts, et al.
Published: (2022-07-01)